デフォルト表紙
市場調査レポート
商品コード
1446394

パイロジェン検査市場:製品・サービス別、検査タイプ別、エンドユーザー別:世界の機会分析と産業予測、2023-2032年

Pyrogen Testing Market By Product and Service, By Test Type, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

出版日: | 発行: Allied Market Research | ページ情報: 英文 286 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
パイロジェン検査市場:製品・サービス別、検査タイプ別、エンドユーザー別:世界の機会分析と産業予測、2023-2032年
出版日: 2024年01月30日
発行: Allied Market Research
ページ情報: 英文 286 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要
Pyrogen Testing Market-IMG1

パイロジェン検査には、エンドトキシン検出のために一般的に採用されているLimulus amebocyte lysate(LAL)試験のような、細菌由来の物質を用いたインビトロ(in vitro)法があります。

その他の方法としては、単球活性化試験(MAT)やウサギパイロジェンテストなどがありますが、倫理的な問題や、より高感度で特異的な代替法があるため、あまり使用されていません。パイロジェン検査の目的は、患者の健康を損なう可能性のあるパイロジェン汚染物質への曝露を防ぐことにより、医療製品の安全性と品質を確保することです。

パイロジェン検査市場の成長を促進する主な要因には、医薬品や医療機器の安全性と品質の確保を重視する傾向の高まり、心臓病、糖尿病、関節炎、がん、糖尿病などの慢性疾患の有病率の急増、医薬品・医療機器に対する需要の増加などがあります。医薬品およびバイオテクノロジー産業における高度な製剤の開拓は、パイロジェン検査市場拡大の重要な促進要因です。医薬品の複雑化により、より多くの品質管理対策の実施が必要となり、パイロジェン検査の採用につながった。加えて、複雑な製剤や最先端の医療技術を導入する製薬・バイオ産業の増加により、高度で高感度なパイロジェン検査手法の必要性が高まっており、これが市場成長の推進力となっています。

さらに、パイロジェンコンタミネーションを最小化するためのイニシアチブの高まりにより、世界の規制機関やヘルスケア機関は厳格な基準を設定するようになりました。このため、強力なパイロジェン検査法の採用が義務付けられ、パイロジェン検査市場の成長に寄与しています。例えば、米国食品医薬品局(FDA)、欧州医薬品庁(EMA)などの規制当局は、パイロジェン検査に関する明確なガイドラインと基準を設定しています。これらのガイドラインは、医薬品・医療機器メーカーが品質管理プロセスの一環として徹底的なパイロジェン試験を実施することに対する規制当局の期待や要件を概説しています。したがって、これらのガイドラインの厳格な遵守は市場成長に大きく寄与します。

また、パイロジェン検査における技術的進歩の高まりは、市場の成長をさらに後押しします。インビトロ法およびインビトロ試験、エンドトキシン試験、組換えC因子アッセイなどの革新的なパイロジェン検出法の開発は、パイロジェン試験プロセスの精度と効率を高めています。例えば、Lonza Groupは、パイロジェン検査の効率と精度を高める先進技術を組み込んだ自動エンドトキシン検査プラットフォーム、PyroTec PROを製造しています。このシステムは、確立されたLimulus Amoebocyte Lysate(LAL)試験法を利用し、試験プロセスを自動化・合理化します。こうした技術的進歩により、製薬メーカーはより信頼性が高く迅速な検査手順を採用できるようになり、市場の成長を後押ししています。

しかし、パイロジェン検査の標準化が限られていることが市場成長の妨げとなっています。また、パイロジェン汚染のリスクや検査手法に関する知識や教育の不足が、新興地域におけるパイロジェン検査の普及を妨げています。これとは対照的に、イノベーションと製品開発に焦点を当てた医療機器産業の拡大と新興諸国における高い成長可能性は、予測期間中に有利な機会を提供すると期待されています。

パイロジェン検査市場は、製品・サービス、検査タイプ、エンドユーザー、地域によって区分されます。製品&サービス別では、市場は試薬&キット、機器、サービスに分類されます。検査タイプ別では、LAL検査、ウサギパイロジェンテスト、その他に分けられます。エンドユーザー別では、製薬・バイオテクノロジー企業、医療機器企業、その他に分類されます。地域別では、北米(米国、カナダ、メキシコ)、欧州(ドイツ、フランス、英国、イタリア、スペイン、その他欧州地域)、アジア太平洋地域(日本、中国、オーストラリア、インド、韓国、その他アジア太平洋地域)、LA(ブラジル、コロンビア、アルゼンチン、その他アジア太平洋地域)、MEA(GCC、南米、北アフリカ、その他MEA地域)で分析されます。

利害関係者にとっての主なメリット

  • 当レポートは、2022年から2032年までのパイロジェン検査市場分析の市場セグメント、現在の動向、推定・動向、ダイナミクスを定量的に分析し、パイロジェン検査市場の有力な機会を特定します。
  • 市場促進要因、市場抑制要因、市場機会に関連する情報とともに市場調査を提供します。
  • ポーターのファイブフォース分析では、利害関係者が利益志向のビジネス決定を行い、サプライヤーとバイヤーのネットワークを強化できるように、バイヤーとサプライヤーの潜在力を強調します。
  • パイロジェン検査市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
  • 各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。
  • 市場企業のポジショニングはベンチマーキングを容易にし、市場企業の現在のポジションを明確に理解することができます。
  • 本レポートには、地域別および世界のパイロジェン検査市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析が含まれています。

利害関係者にとっての主な利点

  • 当レポートでは、2022年から2032年までのパイロジェン検査市場分析の市場セグメント、現在の動向、推定・動向、ダイナミクスを定量的に分析し、パイロジェン検査市場の有力な機会を特定します。
  • 市場促進要因、市場抑制要因、市場機会に関連する情報とともに市場調査を提供します。
  • ポーターのファイブフォース分析では、利害関係者が利益志向のビジネス決定を行い、サプライヤーとバイヤーのネットワークを強化できるように、バイヤーとサプライヤーの潜在力を強調します。
  • パイロジェン検査市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
  • 各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。
  • 市場企業のポジショニングはベンチマーキングを容易にし、市場企業の現在のポジションを明確に理解することができます。
  • 本レポートには、地域別および世界のパイロジェン検査市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析が含まれています。

本レポートで可能なカスタマイズ(追加費用とスケジュールが必要です。)

  • 規制ガイドライン
  • 顧客の関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • 主要企業の詳細(所在地、連絡先、サプライヤー/ベンダーネットワークなどを含む、エクセル形式)

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 影響要因
    • 主な投資機会
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 パイロジェン検査市場:製品・サービス別

  • 概要
  • 試薬とキット
  • 検査機器
  • サービス

第5章 パイロジェン検査市場:検査タイプ別

  • 概要
  • LAL検査
  • ウサギパイロジェン検査(RPT)
  • その他

第6章 パイロジェン検査市場:エンドユーザー別

  • 概要
  • 製薬・バイオテクノロジー企業
  • 医療機器企業
  • その他

第7章 パイロジェン検査市場:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • その他
  • ラテンアメリカ
    • ブラジル
    • コロンビア
    • アルゼンチン
    • その他のラテンアメリカ
  • 中東・アフリカ
    • Gcc
    • 南アフリカ
    • 北アフリカ
    • その他

第8章 競争情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング、2022年

第9章 企業プロファイル

  • Lonza Group AG
  • Thermo Fisher Scientific Inc.
  • Fujifilm Holdings Corporation
  • GenScript
  • SEIKAGAKU CORPORATION
  • Charles River Laboratories
  • STERIS plc
  • Wuxi AppTec
  • Eurofins Scientific SE
  • Merck KGaA
図表

LIST OF TABLES

  • TABLE 01. GLOBAL PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 02. PYROGEN TESTING MARKET FOR REAGENTS AND KITS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. PYROGEN TESTING MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. PYROGEN TESTING MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 06. PYROGEN TESTING MARKET FOR LAL TEST, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. PYROGEN TESTING MARKET FOR RABBIT PYROGEN TEST, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. PYROGEN TESTING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. GLOBAL PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 10. PYROGEN TESTING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. PYROGEN TESTING MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. PYROGEN TESTING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. PYROGEN TESTING MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA PYROGEN TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 18. U.S. PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 19. U.S. PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 20. U.S. PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. CANADA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 22. CANADA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 23. CANADA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE PYROGEN TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 31. GERMANY PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 32. GERMANY PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 33. GERMANY PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. FRANCE PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 36. FRANCE PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. UK PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 38. UK PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 39. UK PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. ITALY PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 41. ITALY PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 42. ITALY PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. SPAIN PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 45. SPAIN PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. REST OF EUROPE PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 47. REST OF EUROPE PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. ASIA-PACIFIC PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 50. ASIA-PACIFIC PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC PYROGEN TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 53. JAPAN PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 54. JAPAN PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 55. JAPAN PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. CHINA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 57. CHINA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 58. CHINA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. INDIA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 60. INDIA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 61. INDIA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. AUSTRALIA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 63. AUSTRALIA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 64. AUSTRALIA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH KOREA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH KOREA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH KOREA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. LATIN AMERICA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 72. LATIN AMERICA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 73. LATIN AMERICA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. LATIN AMERICA PYROGEN TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 75. BRAZIL PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 76. BRAZIL PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 77. BRAZIL PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 78. COLOMBIA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 79. COLOMBIA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 80. COLOMBIA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 81. ARGENTINA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 82. ARGENTINA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 83. ARGENTINA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. REST OF LA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 85. REST OF LA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 86. REST OF LA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 87. MIDDLE EAST AND AFRICA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 88. MIDDLE EAST AND AFRICA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 89. MIDDLE EAST AND AFRICA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 90. MIDDLE EAST AND AFRICA PYROGEN TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 91. GCC PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 92. GCC PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 93. GCC PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 94. SOUTH AFRICA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 95. SOUTH AFRICA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 96. SOUTH AFRICA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 97. NORTH AFRICA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 98. NORTH AFRICA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 99. NORTH AFRICA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 100. REST OF MEA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 101. REST OF MEA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 102. REST OF MEA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 103. LONZA GROUP AG: KEY EXECUTIVES
  • TABLE 104. LONZA GROUP AG: COMPANY SNAPSHOT
  • TABLE 105. LONZA GROUP AG: PRODUCT SEGMENTS
  • TABLE 106. LONZA GROUP AG: SERVICE SEGMENTS
  • TABLE 107. LONZA GROUP AG: PRODUCT PORTFOLIO
  • TABLE 108. LONZA GROUP AG: KEY STRATERGIES
  • TABLE 109. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
  • TABLE 110. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
  • TABLE 111. THERMO FISHER SCIENTIFIC INC. : PRODUCT SEGMENTS
  • TABLE 112. THERMO FISHER SCIENTIFIC INC. : SERVICE SEGMENTS
  • TABLE 113. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
  • TABLE 114. THERMO FISHER SCIENTIFIC INC. : KEY STRATERGIES
  • TABLE 115. FUJIFILM HOLDINGS CORPORATION: KEY EXECUTIVES
  • TABLE 116. FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • TABLE 117. FUJIFILM HOLDINGS CORPORATION: PRODUCT SEGMENTS
  • TABLE 118. FUJIFILM HOLDINGS CORPORATION: SERVICE SEGMENTS
  • TABLE 119. FUJIFILM HOLDINGS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 120. FUJIFILM HOLDINGS CORPORATION: KEY STRATERGIES
  • TABLE 121. GENSCRIPT: KEY EXECUTIVES
  • TABLE 122. GENSCRIPT: COMPANY SNAPSHOT
  • TABLE 123. GENSCRIPT: PRODUCT SEGMENTS
  • TABLE 124. GENSCRIPT: SERVICE SEGMENTS
  • TABLE 125. GENSCRIPT: PRODUCT PORTFOLIO
  • TABLE 126. GENSCRIPT: KEY STRATERGIES
  • TABLE 127. SEIKAGAKU CORPORATION: KEY EXECUTIVES
  • TABLE 128. SEIKAGAKU CORPORATION: COMPANY SNAPSHOT
  • TABLE 129. SEIKAGAKU CORPORATION: PRODUCT SEGMENTS
  • TABLE 130. SEIKAGAKU CORPORATION: SERVICE SEGMENTS
  • TABLE 131. SEIKAGAKU CORPORATION: PRODUCT PORTFOLIO
  • TABLE 132. SEIKAGAKU CORPORATION: KEY STRATERGIES
  • TABLE 133. CHARLES RIVER LABORATORIES: KEY EXECUTIVES
  • TABLE 134. CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT
  • TABLE 135. CHARLES RIVER LABORATORIES: PRODUCT SEGMENTS
  • TABLE 136. CHARLES RIVER LABORATORIES: SERVICE SEGMENTS
  • TABLE 137. CHARLES RIVER LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 138. CHARLES RIVER LABORATORIES: KEY STRATERGIES
  • TABLE 139. STERIS PLC: KEY EXECUTIVES
  • TABLE 140. STERIS PLC: COMPANY SNAPSHOT
  • TABLE 141. STERIS PLC: PRODUCT SEGMENTS
  • TABLE 142. STERIS PLC: SERVICE SEGMENTS
  • TABLE 143. STERIS PLC: PRODUCT PORTFOLIO
  • TABLE 144. STERIS PLC: KEY STRATERGIES
  • TABLE 145. WUXI APPTEC: KEY EXECUTIVES
  • TABLE 146. WUXI APPTEC: COMPANY SNAPSHOT
  • TABLE 147. WUXI APPTEC: PRODUCT SEGMENTS
  • TABLE 148. WUXI APPTEC: SERVICE SEGMENTS
  • TABLE 149. WUXI APPTEC: PRODUCT PORTFOLIO
  • TABLE 150. WUXI APPTEC: KEY STRATERGIES
  • TABLE 151. EUROFINS SCIENTIFIC SE: KEY EXECUTIVES
  • TABLE 152. EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT
  • TABLE 153. EUROFINS SCIENTIFIC SE: PRODUCT SEGMENTS
  • TABLE 154. EUROFINS SCIENTIFIC SE: SERVICE SEGMENTS
  • TABLE 155. EUROFINS SCIENTIFIC SE: PRODUCT PORTFOLIO
  • TABLE 156. EUROFINS SCIENTIFIC SE: KEY STRATERGIES
  • TABLE 157. MERCK KGAA: KEY EXECUTIVES
  • TABLE 158. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 159. MERCK KGAA: PRODUCT SEGMENTS
  • TABLE 160. MERCK KGAA: SERVICE SEGMENTS
  • TABLE 161. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 162. MERCK KGAA: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. PYROGEN TESTING MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF PYROGEN TESTING MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN PYROGEN TESTING MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN PYROGEN TESTING MARKET (2023-2032)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL PYROGEN TESTING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PYROGEN TESTING MARKET FOR REAGENTS AND KITS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF PYROGEN TESTING MARKET FOR INSTRUMENTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PYROGEN TESTING MARKET FOR SERVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. PYROGEN TESTING MARKET, BY TEST TYPE, 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF PYROGEN TESTING MARKET FOR LAL TEST, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF PYROGEN TESTING MARKET FOR RABBIT PYROGEN TEST, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF PYROGEN TESTING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. PYROGEN TESTING MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF PYROGEN TESTING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF PYROGEN TESTING MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF PYROGEN TESTING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. PYROGEN TESTING MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 24. U.S. PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. CANADA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. MEXICO PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. GERMANY PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. FRANCE PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. UK PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. ITALY PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. SPAIN PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. REST OF EUROPE PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. JAPAN PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. CHINA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. INDIA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. AUSTRALIA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. SOUTH KOREA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. REST OF ASIA-PACIFIC PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. BRAZIL PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. COLOMBIA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. ARGENTINA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. REST OF LA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. GCC PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. SOUTH AFRICA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. NORTH AFRICA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. REST OF MEA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 51. COMPETITIVE DASHBOARD
  • FIGURE 52. COMPETITIVE HEATMAP: PYROGEN TESTING MARKET
  • FIGURE 53. TOP PLAYER POSITIONING, 2022
目次
Product Code: A00669
Pyrogen Testing Market - IMG1

Pyrogen testing involves in vitro methods using substances derived from bacterial sources, such as the Limulus amebocyte lysate (LAL) test, which is commonly employed for endotoxin detection. Other methods include the monocyte activation test (MAT) and rabbit pyrogen test, although these are less commonly used due to ethical concerns and the availability of more sensitive and specific alternatives. The goal of pyrogen testing is to ensure the safety and quality of medical products by preventing exposure to pyrogenic contaminants that could compromise patient health.

Key factors that drive the growth of the pyrogen testing market include a rise in emphasis on ensuring the safety and quality of pharmaceutical and medical devices, surge in the prevalence of chronic diseases, such as heart disease, diabetes, arthritis, cancer, & diabetes, and rise in demand for pharmaceuticals & medical devices. The development of advanced formulations in the pharmaceutical and biotechnology industries is a significant driver for the pyrogen testing market expansion. The increase in complexity of pharmaceutical products has necessitated the implementation of more quality control measures, leading to the adoption of pyrogen testing. In addition, the rise in number of pharmaceutical & biotechnology industries introducing complex formulations and cutting-edge medical technologies have led to the need for advanced and sensitive pyrogen testing methodologies, which propel the market growth.

Furthermore, growing initiatives for minimizing pyrogen contamination have led to global regulatory bodies and healthcare organizations to set strict standards. This mandates the adoption of strong pyrogen testing methods, contributing to the growth of the pyrogen testing market. For instance, regulatory authorities, such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and others, have established clear guidelines and standards for pyrogen testing. These guidelines outline the regulatory expectations and requirements for pharmaceutical and medical device manufacturers to conduct thorough pyrogen testing as part of their quality control processes. Thus, stringent adherence to these guidelines contributes significantly to market growth.

Moreover, the rise in technological advancements in pyrogen testing further boosts market growth. The development of innovative pyrogen detection methods, such as in vitro and in vivo testing, endotoxin testing, and recombinant factor C assays, enhances the accuracy and efficiency of pyrogen testing processes. For instance, Lonza Group company manufacture PyroTec PRO, an automated endotoxin testing platform that incorporates advanced technology to enhance the efficiency and accuracy of pyrogen testing. The system utilizes the well-established Limulus Amoebocyte Lysate (LAL) test method automates and streamlines the testing process. These technological advancements enable pharmaceutical manufacturers to adopt more reliable and rapid testing procedures, thereby propelling the market growth.

However, limited standardization for pyrogen testing hinders market growth. In addition, lack of knowledge and education about pyrogen contamination risks and testing methodologies hinder the widespread adoption of pyrogen testing in emerging regions. In contrast, expanding the medical device industry, with a focus on innovation and product development, and high growth potential in emerging countries are expected to provide lucrative opportunities during the forecast period.

The pyrogen testing market is segmented on the basis of product & service, test type, end user, and region. By product & service, the market is classified into reagents & kits, instruments, and services. By test type, the market is divided into LAL tests, rabbit pyrogen test, and others. By end user, it is segregated into pharmaceutical & biotechnology companies, medical device companies, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), LA (Brazil, Colombia, Argentina, and rest of LA), and MEA (GCC, South Africa, North Africa, and rest of MEA).

Major key players that operate in the pyrogen testing market are Merck KGaA, Lonza Group, Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation, GenScript, SEIKAGAKU CORPORATION, Charles River Laboratories, STERIS, WuXi AppTec, and Eurofins Scientific. Key players have adopted product launch as a key developmental strategy to improve the product portfolio of the pyrogen testing market. For instance, in August 2023, Lonza Group launched the Nebula Absorbance Reader, a new absorbance microplate reader which joins the company's portfolio of optimized instruments for streamlined endotoxin and pyrogen testing.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pyrogen testing market analysis from 2022 to 2032 to identify the prevailing pyrogen testing market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the pyrogen testing market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global pyrogen testing market trends, key players, market segments, application areas, and market growth strategies.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pyrogen testing market analysis from 2022 to 2032 to identify the prevailing pyrogen testing market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the pyrogen testing market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global pyrogen testing market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product and Service

  • Reagents and Kits
  • Instruments
  • Services

By Test Type

  • LAL Test
  • Rabbit Pyrogen Test
  • Others

By End User

  • Pharmaceutical and Biotechnology Companies
  • Medical Device Companies
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Colombia
    • Argentina
    • Rest Of La
  • Middle East and Africa
    • Gcc
    • South Africa
    • North Africa
    • Rest Of Mea

Key Market Players:

    • Lonza Group AG
    • Thermo Fisher Scientific Inc.
    • Fujifilm Holdings Corporation
    • GenScript
    • SEIKAGAKU CORPORATION
    • Charles River Laboratories
    • STERIS plc
    • Wuxi AppTec
    • Eurofins Scientific SE
    • Merck KGaA

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Reagents and Kits
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Instruments
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Services
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: PYROGEN TESTING MARKET, BY TEST TYPE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. LAL Test
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Rabbit Pyrogen Test
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: PYROGEN TESTING MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Pharmaceutical and Biotechnology Companies
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Medical Device Companies
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: PYROGEN TESTING MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Product and Service
    • 7.2.3. Market size and forecast, by Test Type
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Product and Service
      • 7.2.5.1.2. Market size and forecast, by Test Type
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Product and Service
      • 7.2.5.2.2. Market size and forecast, by Test Type
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Product and Service
      • 7.2.5.3.2. Market size and forecast, by Test Type
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Product and Service
    • 7.3.3. Market size and forecast, by Test Type
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Product and Service
      • 7.3.5.1.2. Market size and forecast, by Test Type
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Product and Service
      • 7.3.5.2.2. Market size and forecast, by Test Type
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Product and Service
      • 7.3.5.3.2. Market size and forecast, by Test Type
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Product and Service
      • 7.3.5.4.2. Market size and forecast, by Test Type
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Product and Service
      • 7.3.5.5.2. Market size and forecast, by Test Type
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Product and Service
      • 7.3.5.6.2. Market size and forecast, by Test Type
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Product and Service
    • 7.4.3. Market size and forecast, by Test Type
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Product and Service
      • 7.4.5.1.2. Market size and forecast, by Test Type
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Product and Service
      • 7.4.5.2.2. Market size and forecast, by Test Type
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Product and Service
      • 7.4.5.3.2. Market size and forecast, by Test Type
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Product and Service
      • 7.4.5.4.2. Market size and forecast, by Test Type
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Product and Service
      • 7.4.5.5.2. Market size and forecast, by Test Type
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Product and Service
      • 7.4.5.6.2. Market size and forecast, by Test Type
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. Latin America
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Product and Service
    • 7.5.3. Market size and forecast, by Test Type
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Product and Service
      • 7.5.5.1.2. Market size and forecast, by Test Type
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Colombia
      • 7.5.5.2.1. Market size and forecast, by Product and Service
      • 7.5.5.2.2. Market size and forecast, by Test Type
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. Argentina
      • 7.5.5.3.1. Market size and forecast, by Product and Service
      • 7.5.5.3.2. Market size and forecast, by Test Type
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest Of La
      • 7.5.5.4.1. Market size and forecast, by Product and Service
      • 7.5.5.4.2. Market size and forecast, by Test Type
      • 7.5.5.4.3. Market size and forecast, by End User
  • 7.6. Middle East and Africa
    • 7.6.1. Key market trends, growth factors and opportunities
    • 7.6.2. Market size and forecast, by Product and Service
    • 7.6.3. Market size and forecast, by Test Type
    • 7.6.4. Market size and forecast, by End User
    • 7.6.5. Market size and forecast, by country
      • 7.6.5.1. Gcc
      • 7.6.5.1.1. Market size and forecast, by Product and Service
      • 7.6.5.1.2. Market size and forecast, by Test Type
      • 7.6.5.1.3. Market size and forecast, by End User
      • 7.6.5.2. South Africa
      • 7.6.5.2.1. Market size and forecast, by Product and Service
      • 7.6.5.2.2. Market size and forecast, by Test Type
      • 7.6.5.2.3. Market size and forecast, by End User
      • 7.6.5.3. North Africa
      • 7.6.5.3.1. Market size and forecast, by Product and Service
      • 7.6.5.3.2. Market size and forecast, by Test Type
      • 7.6.5.3.3. Market size and forecast, by End User
      • 7.6.5.4. Rest Of Mea
      • 7.6.5.4.1. Market size and forecast, by Product and Service
      • 7.6.5.4.2. Market size and forecast, by Test Type
      • 7.6.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Lonza Group AG
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. Thermo Fisher Scientific Inc.
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Fujifilm Holdings Corporation
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
    • 9.3.7. Key strategic moves and developments
  • 9.4. GenScript
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
    • 9.4.7. Key strategic moves and developments
  • 9.5. SEIKAGAKU CORPORATION
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
    • 9.5.7. Key strategic moves and developments
  • 9.6. Charles River Laboratories
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
    • 9.6.7. Key strategic moves and developments
  • 9.7. STERIS plc
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
    • 9.7.7. Key strategic moves and developments
  • 9.8. Wuxi AppTec
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
    • 9.8.7. Key strategic moves and developments
  • 9.9. Eurofins Scientific SE
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
    • 9.9.7. Key strategic moves and developments
  • 9.10. Merck KGaA
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance
    • 9.10.7. Key strategic moves and developments